Efficacy and safety of nebulized antibiotics in treating ventilator-associated pneumonia
Background Development of ventilator-associated pneumonia (VAP) is associated with high morbidity and mortality rates. VAP mortality ranges between 5.8 and 27%. When administrating intravenous antibiotics they are mainly detected in respiratory segments of the lungs, but not in the sputum and does n...
Main Authors: | Osama S Arafa, Tarek S Essawy, Basem M Abdelgawad, Ashraf M Elnahas, Emad A Attaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2020;volume=69;issue=3;spage=567;epage=571;aulast=Arafa |
Similar Items
-
Effect of Nebulized Eucalyptus on Ventilator Associated Pneumonia in Ventilated Patients
by: Nazanin Amini, et al.
Published: (2019-12-01) -
Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
by: Yinggang Zhu, et al.
Published: (2021-05-01) -
A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
by: Dalia M. El Fawy, et al.
Published: (2020-10-01) -
Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
by: Mona Ahmed Ammar, et al.
Published: (2018-01-01) -
Efficacy of adjuvant colistimethate sodium nebulization in ventilator associated pneumonia in pediatric intensive care unit - A randomized controlled study
by: Anil Sachdev, et al.
Published: (2019-01-01)